A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Genta Inc.

About Genta Inc:

Genta Incorporated is a biopharmaceutical company focused on the identification, development and commercialization of drugs for the treatment of patients with cancer

Genta’s pipeline is anchored by two key programs:

RNA/DNA Medicines (which include products that employ Antisense, RNA interference and Decoys ); and Small Molecules .

The products from each of these platforms address significant unmet medical needs. The Company’s lead drug from its RNA/DNA Medicines program is Genasense® (oblimersen sodium).

Genasense is currently in late-stage clinical trials for the treatment of melanoma, multiple myeloma, chronic lymphocytic leukemia, non-small cell lung cancer, small cell lung cancer and prostate cancer. In December 2003, Genta submitted a New Drug Application (NDA) for Genasense plus chemotherapy for the treatment of patients with advanced malignant melanoma to the U.S. Food and Drug Administration. The Company’s leading drug from its Small Molecules program is Ganite® (gallium nitrate injection).


Clinical Programs

More on Genta Inc.

Home Page for Genta

Key Statistics for Genta

Basic Chart for Genta

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.